HuGE Literature Finder
Records 1-5
|
Upregulation of SMYD3 and SMYD3 VNTR 3/3 polymorphism increase the risk of hepatocellular carcinoma.
Scientific reports 2020 Feb 10 (1): 2797. Binh Mai Thanh, Hoan Nghiem Xuan, Giang Dao Phuong, Tong Hoang Van, Bock C-Thomas, Wedemeyer Heiner, Toan Nguyen Linh, Bang Mai Hong, Kremsner Peter G, Meyer Christian G, Song Le Huu, Velavan Thirumalaisamy |
|
The SMYD3 VNTR 3/3 polymorphism confers an increased risk and poor prognosis of hepatocellular carcinoma in a Chinese population.
Pathology, research and practice 2018 Apr . Li Rui-Dong, Tang Yan-Hua, Wang Hui-Li, Yang Dong, Sun Li-Jun, Li W |
|
Association of the variable number of tandem repeats polymorphism in the promoter region of the SMYD3 gene with risk of esophageal squamous cell carcinoma in relation to tobacco smoking.
Cancer science 2008 Apr 99 (4): 787-91. Wang Haijian, Liu Yang, Tan Wen, Zhang Yang, Zhao Naiqing, Jiang Yan, Lin Chengzhao, Hao Bingtao, Zhao Dan, Qian Ji, Lu Daru, Jin Li, Wei Qingyi, Lin Dongxin, He Fuc |
|
SMYD3 tandem repeats polymorphism is not associated with the occurrence and metastasis of hepatocellular carcinoma in a Chinese population.
Experimental oncology 2007 Mar 29 (1): 71-3. Wang X Q, Miao X, Cai Q, Garcia-Barcelo M M, Fan S |
|
A variable number of tandem repeats polymorphism in an E2F-1 binding element in the 5' flanking region of SMYD3 is a risk factor for human cancers.
Nature genetics 2005 Oct 37 (10): 1104-7. Tsuge Masataka, Hamamoto Ryuji, Silva Fabio Pittella, Ohnishi Yozo, Chayama Kazuaki, Kamatani Naoyuki, Furukawa Yoichi, Nakamura Yusu |
- Page last reviewed:Oct 1, 2020
- Page last updated:Nov 27, 2020
- Content source: